Although the neovascular form of AMD has treatment options in the form of anti-vascular endothelial growth factor therapies,6,7 there are currently no therapies for intermediate AMD, and only one approved treatment exists for geographic atrophy.8 The gene discussed is VEGFA; the disease is age-related macular degeneration.